| 000 | 01556 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513033916.0 | ||
| 264 | 0 | _c19950817 | |
| 008 | 199508s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00013a015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSnyder, S E | |
| 245 | 0 | 0 |
_aSynthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamine. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cJun 1995 |
||
| 300 |
_a2395-409 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnthracenes _xchemical synthesis |
| 650 | 0 | 4 |
_aAzepines _xchemical synthesis |
| 650 | 0 | 4 |
_aBenzazepines _xchemical synthesis |
| 650 | 0 | 4 |
_aDopamine _xanalogs & derivatives |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
| 700 | 1 | _aAviles-Garay, F A | |
| 700 | 1 | _aChakraborti, R | |
| 700 | 1 | _aNichols, D E | |
| 700 | 1 | _aWatts, V J | |
| 700 | 1 | _aMailman, R B | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 38 _gno. 13 _gp. 2395-409 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00013a015 _zAvailable from publisher's website |
| 999 |
_c7608342 _d7608342 |
||